Skip to main content
SpringerLink
Log in

Prevalence and metabolic characteristics of adrenal androgen excess in hyperandrogenic women with different phenotypes

  • Original Articles
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Background: Serum DHEAS has been found to be elevated in some women with polycystic ovary syndrome (PCOS). We wished to determine whether this prevalence is different in women with androgen excess who have different phenotypes and to correlate these findings with various cardiovascular and metabolic parameters. Methods: Two hundred and thirty-eight young hyperandrogenic women categorized into various diagnostic groups were evaluated for elevations in serum DHEAS, testosterone, glucose, insulin, quantitative insulin-sensitivity check index (QUICKI), cholesterol, HDL-C, LDL-C, triglycerides and C-reactive protein (CRP). Data were stratified based on elevations in DHEAS. Results: Serum DHEAS was elevated in 39.5% for the entire group [36.7% in PCOS and 48.3% in idiopathic hyperandrogenism (IHA)]. In classic (C)-PCOS, the prevalence was 39.6% and in ovulatory (OV) PCOS it was 29.1%. These differences were not statistically significant. Women with elevated DHEAS had higher testosterone but lower insulin, higher QUICKI, lower total and LDL-cholesterol and higher HDL-cholesterol, p<0.01. Triglycerides and CRP were not different. This trend was greatest in women with C-PCOS. Conclusions: The prevalence of adrenal hyperandrogenism, as determined by elevations in DHEAS, appears to be statistically similar in IHA, C-PCOS and compared to OV-PCOS. Metabolic and cardiovascular parameters were noted to be more favorable in those women who have higher DHEAS levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lobo RA, Paul WL, Goebelsmann U. Dehydroepiandrosterone sulfate as an indicator of adrenal androgen function. Obstet Gynecol 1981, 57: 69–73.

    PubMed  CAS  Google Scholar 

  2. Carmina E, Stanczyk F, Chang L, Miles RA, Lobo RA. The ratio of androstenedione: 11b-hydroxyandrostenedione is an important marker of adrenal androgen excess in women. Fertil Steril 1992, 58: 148–15.

    PubMed  CAS  Google Scholar 

  3. Rotterdam ESHRE/ASRM Sponsored PCOS Consensus Workshop Group. Revised 2003. Consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004, 81: 19–25.

    Google Scholar 

  4. Rotterdam ESHRE/ASRM Sponsored PCOS Consensus Workshop Group. Revised 2003. Consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Hum Reprod 2004, 19: 41–7.

    Google Scholar 

  5. Carmina E, Lobo RA. Evaluation of hormonal status. In: Strauss III JF, Barbieri RL eds. Yen and Jaffe’s Reproductive Endocrinology: physiology, pathophysiology and clinical management. 5th ed. USA: Elsevier-Saunders. 2004, 939–64.

    Google Scholar 

  6. Carmina E, Rosato F, Jannì A, Rizzo M, Longo RA. Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab 2006, 91: 2–6.

    Article  PubMed  CAS  Google Scholar 

  7. Carmina E, Longo RA, Rini GB, Lobo RA. Phenotypic variation in hyperandrogenic women influences the finding of abnormal metabolic and cardiovascular risk parameters. J Clin Endocrinol Metab 2005, 90: 2545–9.

    Article  PubMed  CAS  Google Scholar 

  8. Carmina E, Orio F, Palomba S, Longo RA, Lombardi G, Lobo RA. Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters. Fertil Steril 2005, 84: 413–9.

    Article  PubMed  CAS  Google Scholar 

  9. Balen AH, Laven JS, Tan SL, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod 2003, 9: 505–14.

    Article  Google Scholar 

  10. Hoffman DI, Klove K, Lobo RA. The prevalence and significance of elevated dehydroepiandrosterone sulfate levels in anovulatory women. Fertil Steril 1984, 42: 76–81.

    PubMed  CAS  Google Scholar 

  11. Stanczyk FZ, Chang L, Carmina E, Putz Z, Lobo RA. Is 11β-hydroxyandrostenedione a better marker of adrenal androgen excess than dehydroepiandrosterone sulfate? Am J Obstet Gynecol 1991, 165: 1837–42.

    Article  PubMed  CAS  Google Scholar 

  12. Carmina E. Prevalence of idiopathic hirsutism. Eur J Endocrinol 1998, 139: 421–3.

    Article  PubMed  CAS  Google Scholar 

  13. Carmina E, Lobo RA. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Fertil Steril 2004, 82: 661–5.

    Article  PubMed  Google Scholar 

  14. Katz A, Sridhar SN, Albert P, et al. Quantitative insulin-sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000, 85: 2402–10.

    Article  PubMed  CAS  Google Scholar 

  15. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 1972, 18: 499–502.

    PubMed  CAS  Google Scholar 

  16. Dominici R, Luraschi P, Franzini C. Measurement of C-reactive protein: two high sensitivity methods compared. J Clin Lab Anal 2004, 18: 280–4.

    Article  PubMed  CAS  Google Scholar 

  17. Carmina E, Rosato F, Janni A. Increased DHEAS levels in PCO syndrome: evidence for the existence of two subgroups of patients. J Endocrinol Invest 1986, 9: 5–9.

    Article  PubMed  CAS  Google Scholar 

  18. Kumar A, Woods KS, Bartolucci AA, Azziz R. Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) 2005, 62: 644–9.

    Article  CAS  Google Scholar 

  19. Carmina E, Koyama T, Chang L, Stanczyk FZ, Lobo RA. Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol 1992, 167: 1807–12.

    Article  PubMed  CAS  Google Scholar 

  20. Carmina E. The spectrum of androgen excess disorders. Fertil Steril 2006, 85: 1582–5.

    Article  PubMed  CAS  Google Scholar 

  21. Moghetti P, Castello R, Negri C, et al. Insulin infusion amplifies 17a-hydroxyxorticosteroid intermediate response to adrenocorticotropin in hyperandrogenicwomen. Apparent relative impairment of 17, 20 lyase activity. J Clin Endocrinol Metab 1996, 81: 881–6.

    CAS  Google Scholar 

  22. Moran C, Knochenhauer E, Boots LR, Azziz R. Adrenal androgen excess in hyperandrogenism: relation to age and body mass. Fertil Steril 1999, 71: 671–4.

    Article  PubMed  CAS  Google Scholar 

  23. Meyer C, Mc Grath BP, Cameron J, Kotsopoulos D, Teede HJ. Vascular disfunction and metabolic parameters in polycystic ovary syndrome. J Clin Endocrinol Metab 2005, 90: 4630–5.

    Article  PubMed  CAS  Google Scholar 

  24. Hougaku H, Fleg JL, Naijar SS, et al. Relationship between androgenic hormones and arterial stiffness based on longitudinal hormone measurements. Am J Physiol Endocrinol Metab 2006, 290: E234–42.

    Article  PubMed  CAS  Google Scholar 

  25. Kawano H, Yasue H, Kitagawa A, et al. Dehydroepiandrosterone supplementation improves endothelial function and insulin sensitivity in men. J Clin Endocrinol Metab 2003, 88: 3190–5.

    Article  PubMed  CAS  Google Scholar 

  26. Barrett-Connor E, Khaw KT, Yen SS. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med 1986, 315: 1519–24.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Medicine, University of Palermo, Via delle Croci 47, 90139, Palermo, Italy

    E. Carmina MD

  2. Department of Obstetrics and Gynaecology, Columbia University, New York, NY, USA

    R. A. Lobo

Authors
  1. E. Carmina MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. A. Lobo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. Carmina MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carmina, E., Lobo, R.A. Prevalence and metabolic characteristics of adrenal androgen excess in hyperandrogenic women with different phenotypes. J Endocrinol Invest 30, 111–116 (2007). https://doi.org/10.1007/BF03347408

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347408

Keywords

Search

Navigation